Annual D&A
$28.80M$3.09M+12.00%
Summary
- Current Value
- As of today, EXEL annual D&A is $28.80M, up +12.00% on
- Historical Performance
- EXEL annual D&A is up +51.90% over the past 3 years, and up +157.93% over the past 5 years
- All-Time High Comparison
- EXEL annual D&A is currently at its all-time high
- 3-Year Low Comparison
- EXEL annual D&A is +37.98% above its 3-year low of $20.88M reached on an earlier date
- Sector Comparison
- EXEL annual D&A is higher than 81.38% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| $28.80M | +12.0% | +51.9% | +157.9% | +128.7% | ||
| $7.42M | -0.4% | -33.4% | +107.4% | +208.9% | ||
| $29.75M | +7.5% | -1.4% | +93.0% | +163.0% | ||
| Price | $41.36 | +25.6% | +137.8% | +86.2% | +379.8% | |
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| $1.65B | +1.5% | +36.8% | +154.7% | +474.1% | ||
| $1.40B | -11.6% | +28.0% | +148.2% | +1050.5% | ||
| Annual Revenue | $2.17B | +18.5% | +51.1% | +124.1% | +1329.0% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $28.80M | at high | |
| 5Y | $28.80M | at high | |
| All | $28.80M | at high |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $20.88M | N/A | +38.0% |
| 5Y | $13.97M | N/A | +106.2% |
| All | $731.00K | +3840.2% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of EXEL?
As of today, EXEL annual D&A is $28.80M
What is 1-year change in EXEL annual D&A?
EXEL annual D&A is up +12.00% year-over-year
What is 3-year change in EXEL annual D&A?
EXEL annual D&A is up +51.90% over the past 3 years
How far is EXEL annual D&A from its all-time high?
EXEL annual D&A is currently at its all-time high
How does EXEL annual D&A rank versus sector peers?
EXEL annual D&A is higher than 81.38% of companies in Healthcare sector
When is EXEL next annual earnings release?
The next annual earnings release for EXEL is on
Quarterly D&A
$7.42M$80.00K+1.09%
Summary
- Current Value
- As of today, EXEL quarterly D&A is $7.42M, up +1.09% on
- Historical Performance
- EXEL quarterly D&A is down -0.43% year-over-year, and down -33.44% over the past 3 years
- All-Time High Comparison
- EXEL quarterly D&A is currently -45.37% below its historical high of $13.59M set on
- 3-Year Low Comparison
- EXEL quarterly D&A is +196.59% above its 3-year low of -$7.68M reached on
- Sector Comparison
- EXEL quarterly D&A is higher than 80.65% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| $7.42M | +1.1% | -0.4% | -33.4% | +107.4% | ||
| $28.80M | – | +12.0% | +51.9% | +157.9% | ||
| $29.75M | -0.1% | +7.5% | -1.4% | +93.0% | ||
| Price | $41.36 | +6.2% | +25.6% | +137.8% | +86.2% | |
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| $404.18M | +5.4% | -4.1% | +19.4% | +53.6% | ||
| $322.83M | -3.7% | -3.5% | +2.9% | +21.9% | ||
| Quarterly Revenue | $597.76M | +5.2% | +10.8% | +45.2% | +158.7% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $7.64M | N/A | -2.9% |
| 3Y | $13.59M | -45.4% | |
| 5Y | $13.59M | -45.4% | |
| All | $13.59M | -45.4% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $7.34M | +1.1% | |
| 3Y | -$7.68M | +196.6% | |
| 5Y | -$7.68M | +196.6% | |
| All | -$7.68M | +196.6% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of EXEL?
As of today, EXEL quarterly D&A is $7.42M
What is EXEL quarterly D&A most recent change?
EXEL quarterly D&A was up +1.09% on September 1, 2025
What is 1-year change in EXEL quarterly D&A?
EXEL quarterly D&A is down -0.43% year-over-year
How far is EXEL quarterly D&A from its all-time high?
EXEL quarterly D&A is currently -45.37% below its historical high of $13.59M set on March 31, 2023
How does EXEL quarterly D&A rank versus sector peers?
EXEL quarterly D&A is higher than 80.65% of companies in Healthcare sector
When is EXEL next earnings release?
The next earnings release for EXEL is on
TTM D&A
$29.75M$32.00K-0.11%
Summary
- Current Value
- As of today, EXEL TTM D&A is $29.75M, down -0.11% on
- Historical Performance
- EXEL TTM D&A is up +7.45% year-over-year, and down -1.39% over the past 3 years
- All-Time High Comparison
- EXEL TTM D&A is currently -7.15% below its historical high of $32.04M set on
- 3-Year Low Comparison
- EXEL TTM D&A is +137.08% above its 3-year low of $12.55M reached on
- Sector Comparison
- EXEL TTM D&A is higher than 80.84% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| $29.75M | -0.1% | +7.5% | -1.4% | +93.0% | ||
| $28.80M | – | +12.0% | +51.9% | +157.9% | ||
| $7.42M | +1.1% | -0.4% | -33.4% | +107.4% | ||
| Price | $41.36 | +6.2% | +25.6% | +137.8% | +86.2% | |
| -$587.54M | -213.4% | -220.1% | -233.6% | -318.5% | ||
| TTM Revenue | $2.29B | +2.6% | +9.9% | +39.7% | +138.9% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $29.78M | -0.1% | |
| 3Y | $32.04M | -7.2% | |
| 5Y | $32.04M | -7.2% | |
| All | $32.04M | -7.2% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $28.80M | N/A | +3.3% |
| 3Y | $12.55M | +137.1% | |
| 5Y | $12.55M | +137.1% | |
| All | $440.00K | +6661.6% |
TTM D&A History
FAQ
What is the current TTM D&A of EXEL?
As of today, EXEL TTM D&A is $29.75M
What is EXEL TTM D&A most recent change?
EXEL TTM D&A was down -0.11% on September 1, 2025
What is 1-year change in EXEL TTM D&A?
EXEL TTM D&A is up +7.45% year-over-year
How far is EXEL TTM D&A from its all-time high?
EXEL TTM D&A is currently -7.15% below its historical high of $32.04M set on June 30, 2023
How does EXEL TTM D&A rank versus sector peers?
EXEL TTM D&A is higher than 80.84% of companies in Healthcare sector
When is EXEL next earnings release?
The next earnings release for EXEL is on
Data Sources & References
- EXEL Official Website www.exelixis.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/939767/000093976725000019/0000939767-25-000019-index.htm
- EXEL Profile on Yahoo Finance finance.yahoo.com/quote/EXEL
- EXEL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/exel